Literature DB >> 19026168

Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.

Caterina Mammina1, Paola Di Carlo, Domenico Cipolla, Alessandra Casuccio, Matilde Tantillo, Maria Rosa Anna Plano, Angela Mazzola, Giovanni Corsello.   

Abstract

AIM: We describe a one-year investigation of colonization by imipenemresistant, metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa in a neonatal intensive care unit (NICU) of the University Hospital of Palermo, Italy.
METHODS: A prospective epidemiological investigation was conducted in the period 2003 January to 2004 January. Rectal swabs were collected twice a week from all neonates throughout their NICU stay. MBL production by imipenem-resistant strains of P aeruginosa was detected by phenotypic and molecular methods. Pulsed field gel electrophoresis (PFGE) was carried out on all isolates of P aeruginosa. The association between risk factors and colonization by imipenem-resistant, imipenem-susceptible P aeruginosa isolates and other multidrug-resistant Gram negative (MDRGN) organisms was analyzed for variables present at admission and during the NICU stay. Data analysis was carried out by the Cox proportional hazards regression model.
RESULTS: Twentytwo of 210 neonates were colonized with imipenem-resistant, MBL-producing P aeruginosa isolates and 14 by imipenem-susceptible P aeruginosa isolates. A single pulsotype, named A, was shared by all imipenem-resistant isolates. Colonization by P aeruginosa of pulsotype A was positively correlated with breast milk feeding and administration of ampicillin-sulbactam, and inversely correlated with exclusive feeding by formula. In the Cox proportional hazards regression model, birthweight of more than 2500 g and breast milk feeding were independently associated with an increased risk of colonization by MBL producing P aeruginosa.
CONCLUSION: The results strongly support an association between colonization by a well-defined imipenem-resistant, MBL producing P aeruginosa strain and breast milk feeding. Such a study may highlight the need for implementation of strategies to prevent expressed breast milk from becoming a vehicle of health care-associated infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026168     DOI: 10.1111/j.1745-7254.2008.00892.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  4 in total

1.  Pseudomonas aeruginosa outbreak linked to mineral water bottles in a neonatal intensive care unit: fast typing by use of high-resolution melting analysis of a variable-number tandem-repeat locus.

Authors:  F Naze; E Jouen; R T Randriamahazo; C Simac; P Laurent; A Blériot; F Chiroleu; L Gagnevin; O Pruvost; A Michault
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

Review 2.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

3.  Efficacy of a coordinated strategy for containment of multidrug-resistant Gram-negative bacteria carriage in a Neonatal Intensive Care Unit in the context of an active surveillance program.

Authors:  Laura Saporito; Giorgio Graziano; Federica Mescolo; Emanuele Amodio; Vincenzo Insinga; Grazia Rinaudo; Aurora Aleo; Celestino Bonura; Marcello Vitaliti; Giovanni Corsello; Francesco Vitale; Carmelo Massimo Maida; Mario Giuffrè
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-04       Impact factor: 4.887

4.  Expressed Breast Milk Contamination in Neonatal Intensive Care Unit.

Authors:  Suzan Gad; Mohamed M Sheta; Abeer I Al-Khalafawi; Heba A Abu El-Fadl; Maha Anany; Shaimaa Sahmoud; Mona Karem Amin
Journal:  Pediatric Health Med Ther       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.